{"0f72865d-fe3e-4163-918f-27e7c84781c3": "This recent safety communication from FDA highlights recent healthcare outbreak activity. FDA has become increasingly aware of drug products compounded at medical offices and clinics that were prepared under insanitary conditions. FDA has also become aware of business models, such as intravenous (IV) hydration clinics, medical spas, and mobile IV infusion services, that are compounding drugs that may not meet the conditions of section 503A of the FD&amp;C Act or comply with state regulations. Contaminated, or otherwise poor quality, compounded drug products can lead to serious patient illnesses, including death.", "8e258b49-53ff-4566-8088-a5161e4a62cc": "FDA highlights concerns with compounding of drug products by medical offices and clinics under insanitary conditions"}